FDA Inspection 1221173 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on Oct 18, 2023 in Pembroke Pines, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 18, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pembroke Pines, FL (United States)